Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08VMW
|
||||
Former ID |
DIB015816
|
||||
Drug Name |
MP-529
|
||||
Synonyms |
SGI-1097; SGI-1215; SGI-498; SGI-503; Oral aurora kinase inhibitor (cancer), Montigen
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543524] | ||
Company |
Montigen Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(c1ccc(NC(=S)N2CCN(c3ncnc4c3c3c(cc(c(c3)OC)OC)[n<br />H]4)CC2)cc1)Nc1ccc(cc1)F
|
||||
Target and Pathway | |||||
Target(s) | Aurora protein kinase | Target Info | Inhibitor | [543524] | |
KEGG Pathway | Oocyte meiosis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.